This is in agreement with another study, which has demonstrated that rs9895829 alone or in combination with other TP53 single nucleotide polymorphisms (SNPs) is associated with increased levels of Δ133TP53 and TP53β (likely to be Δ133TP53β) and poor outcomes in glioblastoma and prostate cancer [50]. Here, TP53 is linked to prostate carcinoma.